De‐Wei Wu

Paxillin Predicts Survival and Relapse in Non–Small Cell Lung Cancer by MicroRNA-218 Targeting

De‐Wei Wu, Ya‐Wen Cheng, John Wang et al. · Cancer Research · 2010 · 129 citations

Medicine, Cancer Biology, Oncology +17

Reduced p21WAF1/CIP1 via Alteration of p53-DDX3 Pathway Is Associated with Poor Relapse-Free Survival in Early-Stage Human Papillomavirus–Associated Lung Cancer

De‐Wei Wu, Wen-Shan Liu, John Wang et al. · Clinical Cancer Research · 2011 · 95 citations

Medicine, Molecular Biology, Oncology +17

Mitochondrial CMPK2 mediates immunomodulatory and antiviral activities through IFN-dependent and IFN-independent pathways

Jenn‐Haung Lai, De‐Wei Wu, Chien‐Hsiang Wu et al. · iScience · 2021 · 68 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting

De‐Wei Wu, Chun-Yi Chuang, Wea-Long Lin et al. · Carcinogenesis · 2014 · 58 citations

Medicine, Cancer Biology, Oncology +16

Loss of TIMP-3 Promotes Tumor Invasion via Elevated IL-6 Production and Predicts Poor Survival and Relapse in HPV-Infected Non–Small Cell Lung Cancer

De‐Wei Wu, Lung‐Hung Tsai, Po-Ming Chen et al. · American Journal Of Pathology · 2012 · 56 citations · Full text

Medicine, Cancer Biology, Oncology +10